Member Info for Aldebaran

An article isn't going to lift the price of hemo not now not in this market i think that's wishful thinking.

I read somewhere that when comparing avacta to hemo there was no comparison at all from a risk reward perspective. The article went on to say avacta is in a league of its own and the ceo has confirmed last week they have the holy grail in cancer treatment yet shares haven't budged. Its all about sales. Looks like avacta have to wait 2 years for sales which feels like forever but at least they are funded now for at least 2 years.

What is the cash position here at hemo looking like and when are they expecting sales?

JWBellamy perhaps you could answer as you seem to know everything about hemo and are trying to cross ramp it on other bulletin boards like your post on avacta today

It is obvious now the science works I think everyone agrees on that

So when do Avacta actually let the world know?

I imagine it will be when the 1st line patients they are treating all are seeing stable disease or tumour regression so can make a splash in the media with some human stories

When will that be ? are the 2 weekly dosed patients taking AVa6000 as a first line treatment?

Gje excellent thank you.

At 50p a share then our quarterly payment will sting but given the volume traded here it will come and go pretty quickly. That's if they haven't already been forward selling which I know they're not supposed to but neither are placings supposed to be leaked or insiders to trade etc and it happens

Gje again thanks. So if we don't get clobbered by conversion I.e. heights don't convert to shares then dump on the market how will we get clobbered financially i am really struggling to understand this cln and you seem to have a great handle on it and are willing to share as well.

Does this mean we have to pay back the money this quarter in cash if the share price is below the conversion price?

There's a lot of nonsense and arguing on this bored so useful information like you have posted us highly appreciated and refreshing. Thank you

Gje this is all very complicated but appreciate the work you have put into it.

What does it mean in simple terms tho

How do we watch presentation later is there a link

How many shares have traded since being admitted guys any clue?

Wondering when the churn will end

Years am long now m8.

MMs searching for liquidity also isn't helping

Sorry to sound callous but if patients take it for longer does that mean more profit for avacta?

Precautionary chemo they say. Wow.

Sorry to be so cold and sounding harsh it first goes without saying this is terrible news etc...

But the thing with chemo and specific the avacta chemo is that is flushes the entire body so any small little undetected tumours hugh in FAP will be targeted.

Despite other treatments advancing all the time I don't see chemo goes away especially if it can ve delivered without any severe side effects.

Kates body will be ravished by chemo bless her. Big pharma have a responsibility to buy avacta ASAP AND put multiple indications into trial immediately.

When people see what chemo has done to Kate especially if she loses her hair etc and then avacta come out with some human stories of delivering chemo without side affect then obviously this will be fantastic for the company

But goes without saying dreadful for Kate and her family

All going the same way

Their just isn't money in this its all hype and hope

So what happens if share price stays 50p forvever they just don't get there money back?

Are heights forward selling again. 75k trade at end if the day looks suspicious like there's always does

50p placing price like a magnet right now as everyone anticipating a sell of

Probably will get quite a few flipping for 10pc but don't see this going below 50p and if it does I'd expect the shares to be very quickly snapped up.

Need to see the results of the trials latest data and if presented well at aacr then surely there will be buying flurry as people realise just how likely it is ava6000 comes to market within just a couple of short years.

Market cap offering insane value here if ava6000 comes to market. Insane

Market expecting a charity fundraise here perhaps?

Company releasing news to try and bolster price before a funraise but market isn't having it by looks of it

Little fish panicing

big fish gobbling up?

From 13th December:

4. The next steps with AVA6000 involve optimising the patient population, dose and schedule in order to increase efficacy and tolerability of doxorubicin treatment via pre|CISIONTM targeting. Given the favourable safety data from the three-weekly dosing study, a fortnightly dosing study, which is now screening patients with high FAP levels in the United States, will assist in optimising the schedule and dose for a potentially pivotal Phase 2 study in 2024.

Anyone know what has happened since then have Avacta found the patients they need and started the fortnightly dosing. When can we expect some next news?

This post here for anyone not seen it https://x.com/MylesMcNulty/status/1621591088095002626?s=20